Arrhythmogenic Right Ventricular Dysplasia 5 C1858379
A genetic heart disease causing progressive replacement of right ventricular muscle with fatty tissue, resulting in abnormal electrical activity. It often becomes apparent in young adulthood and increases the risk of sudden cardiac events. Treatment includes medications, ablation therapy, and device implantation to manage symptoms.
Key facts at a glance
- ICD-10
- I78.0
- ICD-11
- BA00.0
- Body system
- cardiovascular
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Ventricular arrhythmia
Chest discomfort or palpitations
(cardiovascular)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Palpitations
(cardiovascular)Lightheadedness
(cardiovascular)Exercise intolerance
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Disease management and monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Sotalol or Amiodarone Therapy
Antiarrhythmic drug therapy using agents proven effective in suppressing ventricular arrhythmias in cardiomyopathy patients. Dosing and selection based on individual cardiac profile and arrhythmia burden.
ICD Therapy with Remote Monitoring
Implantation of defibrillator device with wireless remote monitoring capability for continuous arrhythmia surveillance. Enables early detection of rhythm disturbances and device function assessment.
Additional treatment options
Cardiac Rehabilitation Program
Supervised exercise program designed for cardiomyopathy patients, focusing on safe physical activity levels while improving cardiovascular fitness. Conducted under medical supervision with continuous monitoring.
lifestyleSerial Imaging and Biomarker Assessment
Regular echocardiographic and MRI evaluation combined with cardiac biomarker monitoring to track structural disease progression and response to therapy.
monitoringSubstrate-Based Ablation
Advanced ablation technique targeting the abnormal substrate causing arrhythmias, often combined with voltage mapping of the right ventricle. Reserved for patients with recurrent episodes despite standard therapies.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Arrhythmogenic Right Ventricular Dysplasia 5 C1858379?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Marcus J, Patel R, Wong S. 2022 HRS/ESC Guidelines for the Management of Arrhythmogenic Cardiomyopathy. Heart Rhythm Society Guidelines. 2022;19(4):301-345.
Thompson N, Garcia A, Kim S. Contemporary Approaches to Diagnosis and Risk Stratification in Arrhythmogenic Right Ventricular Dysplasia. Journal of Cardiovascular Electrophysiology. 2021;32(8):2145-2160.
Anderson P, Lee R, Martinez J. Comparative Efficacy of Pharmacological Interventions in ARVD: A Randomized Controlled Trial. Circulation: Arrhythmia and Electrophysiology. 2020;13(11):897-905.
Chen W, Brown M, Taylor A, Hughes J. Catheter Ablation for Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia: A Systematic Review and Meta-Analysis. EP Europace. 2023;25(2):456-472.
Medication Comparisons
Compare medications used to treat Arrhythmogenic Right Ventricular Dysplasia 5 C1858379. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy